Results 91 to 100 of about 6,419,132 (171)
Glucagon-like peptide-1 receptor agonists (arGLP-1) demonstrate considerable efficacy in the management of obesity and type 2 diabetes mellitus. Nonetheless, their clinical application is often restricted due to gastrointestinal adverse events, such as ...
Dmitry N. Andreev, Yury A. Kucheryavyy
doaj +1 more source
Effect of mesalazine on epithelial cell proliferation in colonic diverticular disease
Background and aims: increased epithelial cell proliferation may be detected in diverticular disease, but antibiotics have failed in reducing it. We assess therefore the effect of mesalazine on epithelial cell proliferation in diverticular disease ...
ELISEI W +11 more
core +1 more source
Diarrhea management: from pathophysiology to microbiota modulation
Diarrhea, whether acute or chronic, is a common clinical condition with numerous causes that collectively impose significant health, economic, social, and psychological burdens worldwide.
Giovanni Marasco +6 more
doaj +1 more source
Aim. The standard therapeutic approach for symptomatic uncomplicated diverticular disease (DD) remains to be defined, and only a few studies have tested the efficacy of probiotics in these patients. Methods.
ANNIBALE, Bruno +7 more
core
Probiotics and Diverticular Disease. Evidence-based?
Diverticular disease (DD) is a common gastrointestinal condition. Clinical spectrum ranges from asymptomatic diverticulosis to symptomatic uncomplicated or complicated DD. Symptoms related to uncomplicated DD are not specific and may be indistinguishable
ANNIBALE, Bruno, LAHNER, EDITH
core +1 more source
Background and Aims: Symptomatic Uncomplicated Diverticular Disease (SUDD) may recur, but it is still unknown whether the gut microbiota (GM) may play a role. We aimed to analyze whether GM plays a role in short-term (6 months) relapse in SUDD patients for whom GM data were retrospectively available.
Antonio, Tursi +20 more
openaire +2 more sources
Management of symptomatic uncomplicated diverticular disease (SUDD) of the colon with Clostridium butyricum CBM588 versus rifaximin: a retrospective cross-sectional study. [PDF]
Urgesi R +13 more
europepmc +1 more source
Aim: To comparatively ate the long term efficacy of Rifaximin and dietary fibers in reducing symptoms and/or complication frequency in symptomatic, uncomplicated diverticular disease. Methods: 307 patients (118 males, 189 females, age range: 40-80 years)
Roda, Enrico +7 more
core
[Modern indications on the medical treatment of symptomatic diverticular disease].
Authors refer about their experience on treatment of symptomatic diverticular disease both with antibiotic and anti-inflammatory drugs. They confirm the observation of other Authors on effectiveness of this new therapeutic approach versus traditional ...
DI FULVIO, Annunziata +5 more
core
Site and duration of abdominal pain discriminate symptomatic uncomplicated diverticular disease from previous diverticulitis patients. [PDF]
Carabotti M +8 more
europepmc +1 more source

